These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure. Brogden RN; Todd PA; Sorkin EM Drugs; 1988 Nov; 36(5):540-600. PubMed ID: 3063499 [TBL] [Abstract][Full Text] [Related]
23. An overview of the clinical pharmacology of enalapril. Davies RO; Gomez HJ; Irvin JD; Walker JF Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):215S-229S. PubMed ID: 6099737 [TBL] [Abstract][Full Text] [Related]
24. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option. Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075 [TBL] [Abstract][Full Text] [Related]
25. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects. Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164 [TBL] [Abstract][Full Text] [Related]
27. Enalapril following captopril-induced nephrotic syndrome. Webb DJ; Atkinson AB Scott Med J; 1986 Jan; 31(1):30-2. PubMed ID: 3008324 [TBL] [Abstract][Full Text] [Related]
28. Enalapril in hypertension and congestive heart failure. Overall review of efficacy and safety. Moncloa F; Sromovsky JA; Walker JF; Davies RO Drugs; 1985; 30 Suppl 1():82-9. PubMed ID: 2864229 [TBL] [Abstract][Full Text] [Related]
29. [Reproducibility of acute captopril-induced renal insufficiency with enalapril]. Cremer W Klin Wochenschr; 1984 Jan; 62(1):43-5. PubMed ID: 6321850 [TBL] [Abstract][Full Text] [Related]
30. Captopril--an overview. Rosendorff C S Afr Med J; 1982 Oct; 62(17):593-9. PubMed ID: 6214858 [TBL] [Abstract][Full Text] [Related]
31. Does the duration of action of angiotensin converting enzyme inhibitors affect their safety and adverse effects? Frank GJ J Hypertens Suppl; 1989 Sep; 7(5):S17-22. PubMed ID: 2553900 [TBL] [Abstract][Full Text] [Related]
32. Clinical pharmacology of the angiotensin converting enzyme inhibitor, enalapril. Brunner HR; Nussberger J; Waeber B Acta Cardiol; 1986; 41(5):341-50. PubMed ID: 3022510 [TBL] [Abstract][Full Text] [Related]
33. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril. Turini GA; Waeber B; Brunner HR Eur Heart J; 1983 Jan; 4 Suppl A():189-97. PubMed ID: 6301835 [TBL] [Abstract][Full Text] [Related]
37. Enalapril: a second-generation angiotensin converting enzyme inhibitor. Bajaj AK Am J Med Sci; 1988 Nov; 296(5):332-5. PubMed ID: 2848421 [No Abstract] [Full Text] [Related]
38. [Side effects induced by captopril. Comparison of a series of hypertensive patients with renal failure and a series with cardiac failure]. Kayanakis JG; Doat P; Grenet B; Albagnac N; Fauvel JM; Durand D; Suc JM; Bounhoure JP Arch Mal Coeur Vaiss; 1983 Sep; 76(9):1065-71. PubMed ID: 6227300 [TBL] [Abstract][Full Text] [Related]
39. Safety issues during antihypertensive treatment with angiotensin converting enzyme inhibitors. Weber MA Am J Med; 1988 Apr; 84(4A):16-23. PubMed ID: 3064605 [TBL] [Abstract][Full Text] [Related]
40. Long-term renal effects of enalapril therapy in patients with renal insufficiency. Smith RD; Rodel PV; Mulcahy WS; Price BA Nephron; 1990; 55 Suppl 1():49-58. PubMed ID: 2189074 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]